BVF Inc’s AC Immune ACIU Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $54.5M | Hold |
19,822,436
| – | – | 1.74% | 20 |
|
|
2025
Q4 | $62.2M | Hold |
19,822,436
| – | – | 2.1% | 16 |
|
|
2025
Q3 | $57.3M | Hold |
19,822,436
| – | – | 2.32% | 16 |
|
|
2025
Q2 | $40.2M | Hold |
19,822,436
| – | – | 1.44% | 15 |
|
|
2025
Q1 | $37.1M | Buy |
19,822,436
+300,000
| +2% | +$756K | 1.51% | 13 |
|
|
2024
Q4 | $52.7M | Hold |
19,522,436
| – | – | 1.79% | 13 |
|
|
2024
Q3 | $73.8M | Buy |
19,522,436
+687,500
| +4% | +$2.4M | 2.16% | 13 |
|
|
2024
Q2 | $75.2M | Buy |
18,834,936
+4,263,700
| +29% | +$14.1M | 2.11% | 17 |
|
|
2024
Q1 | $43.1M | Hold |
14,571,236
| – | – | 1.19% | 25 |
|
|
2023
Q4 | $72.9M | Buy |
14,571,236
+7,142,857
| +96% | +$23M | 1.82% | 14 |
|
|
2023
Q3 | $21.2M | Hold |
7,428,379
| – | – | 0.57% | 34 |
|
|
2023
Q2 | $22M | Hold |
7,428,379
| – | – | 0.61% | 33 |
|
|
2023
Q1 | $17.4M | Hold |
7,428,379
| – | – | 0.64% | 43 |
|
|
2022
Q4 | $15.2M | Hold |
7,428,379
| – | – | 0.64% | 43 |
|
|
2022
Q3 | $23.5M | Hold |
7,428,379
| – | – | 0.97% | 34 |
|
|
2022
Q2 | $26.8M | Hold |
7,428,379
| – | – | 1.3% | 26 |
|
|
2022
Q1 | $29.7M | Buy |
7,428,379
+366,000
| +5% | +$1.58M | 1.19% | 27 |
|
|
2021
Q4 | $35M | Buy |
7,062,379
+127,200
| +2% | +$739K | 1.27% | 26 |
|
|
2021
Q3 | $46.5M | Sell |
6,935,179
-1,610,000
| -19% | -$11.5M | 1.82% | 17 |
|
|
2021
Q2 | $67.8M | Buy |
8,545,179
+1,040,600
| +14% | +$7.19M | 2.54% | 13 |
|
|
2021
Q1 | $57.1M | Sell |
7,504,579
-2,312,079
| -24% | -$16.5M | 2.14% | 15 |
|
|
2020
Q4 | $50.8M | Sell |
9,816,658
-2,100
| -0% | -$10.7K | 2% | 15 |
|
|
2020
Q3 | $47.9M | Sell |
9,818,758
-1,500,000
| -13% | -$10.8M | 2.61% | 10 |
|
|
2020
Q2 | $76.2M | Sell |
11,318,758
-23,747
| -0.2% | -$173K | 4.7% | 7 |
|
|
2020
Q1 | $78.4M | Hold |
11,342,505
| – | – | 7.31% | 3 |
|
|
2019
Q4 | $96.6M | Buy |
11,342,505
+44,594
| +0.4% | +$297K | 7.33% | 3 |
|
|
2019
Q3 | $55.9M | Buy |
11,297,911
+1,478,477
| +15% | +$7.92M | 5.88% | 4 |
|
|
2019
Q2 | $54.5M | Buy |
9,819,434
+2,363,900
| +32% | +$12M | 5.95% | 4 |
|
|
2019
Q1 | $37.6M | Buy |
7,455,534
+5,225,507
| +234% | +$33.2M | 4.22% | 6 |
|
|
2018
Q4 | $21.1M | Buy |
2,230,027
+212,527
| +11% | +$2.01M | 2.75% | 12 |
|
|
2018
Q3 | $16.1M | Buy |
+2,017,500
| New | +$20.3M | 1.42% | 23 |
|
Other funds holding ACIU
DIG
BVF Inc's ACIU Position: Q1 2026 in Review
BVF Inc held its AC Immune (ACIU) position steady in Q1 2026 at 19,822,436 shares worth $54.5M. The position accounts for 1.74% of the portfolio, ranked #20.
BVF Inc first reported a position in ACIU in Q3 2018 and has held it in 31 quarters since. The position peaked at $96.6M in Q4 2019. 46 funds tracked by Wall St. Rank hold ACIU as of Q1 2026.
- BVF Inc held 19,822,436 shares of AC Immune worth $54.5M as of Q1 2026.
- BVF Inc left its AC Immune share count unchanged in Q1 2026.
- AC Immune made up 1.74% of BVF Inc's portfolio in Q1 2026, its #20 holding.
- BVF Inc first reported a position in AC Immune in Q3 2018 and has held it in 31 quarters since.
- BVF Inc's AC Immune position peaked at $96.6M in Q4 2019.
- 46 funds tracked by Wall St. Rank held AC Immune as of Q1 2026.
Based on BVF Inc's 13F filing for Q1 2026, filed 15 May 2026.